Pilot Study of Endothelin Receptor Blockade in Heart Failure with Diastolic Dysfunction and Pulmonary Hypertension (BADDHY-Trial)

2017 ◽  
Vol 26 (5) ◽  
pp. 433-441 ◽  
Author(s):  
B. Koller ◽  
R. Steringer-Mascherbauer ◽  
C.H. Ebner ◽  
Th. Weber ◽  
M. Ammer ◽  
...  
2012 ◽  
Vol 2 (4) ◽  
pp. 461-469 ◽  
Author(s):  
Aikaterini J. Megalou ◽  
Chryssoula Glava ◽  
Agapi D. Vilaeti ◽  
Dimitrios L. Oikonomidis ◽  
Giannis G. Baltogiannis ◽  
...  

2020 ◽  
Vol 11 (3) ◽  
pp. 4608-4618
Author(s):  
Patta Prashant ◽  
Ramu Gogisetty ◽  
Vyshnavi Tallapaneni ◽  
Veera Venkata Satyanarayana Reddy Karri

Chronic disorders or diseases like hypertension, diabetes-mellitus, cancer, heart failure, pulmonary hypertension are becoming more prevalent nowadays even at a younger age. Various methods have been introduced to determine several diseases out of which the concept of measurement of endothelins and matrix metalloproteinases and the usage of endothelin receptor antagonist as a way of treatment either singly or combinedly with other drugs has achieved more importance. By the usage of serum matrix metalloproteinases (MMPs) and endothelins we can determine the people who are at risk of developing hypertension, type2 diabetes, heart failure, atherosclerosis, cancer, pulmonary hypertension and can also assess the range of complications that are going to occur in the individual. These elevated levels cause remodelling after a period of time. Hence, the detection is done through a method in which few factors like endothelins and MMPs of our body are measured through a blood sample, maximum benefits can be obtained in individuals who have a significant family history of developing hypertension and other conditions In this review we have discussed about various effects of endothelins in different conditions, and also to know if these conditions can be improved or not by using endothelin receptor antagonists.


Sign in / Sign up

Export Citation Format

Share Document